THE APPLICATION OF GUIDLINS FOR THE PREVENTION OF INFECTIVE ENDOCARDITIS BY DENTISTS IN KAZAKHSTAN: A CROSS-SECTIONAL STUDY
Introduction. Awareness and clinical application of the guiding principles for the prevention of infective endocarditis (IE) among dental practitioners is one of the key factors influencing morbidity rates.
Aim. To assess the level of awareness and the implementation of IE prevention guidelines among dentists in Kazakhstan.
Materials and Methods. A cross-sectional study was conducted among 80 dental practitioners. A prognostic model was constructed using logistic regression and the CHAID method. Statistical analysis was performed using SPSS software (version 26.0).
Results. According to the findings, only 5% of dentists were fully informed about the potential risks of developing IE following invasive dental procedures and the recommendations for its prevention. Among the respondents, 88.8% highlighted the need to inform dentists regarding the dental management of patients with cardiovascular diseases at an interdisciplinary level. Furthermore, 70.1% of physicians emphasized the necessity of creating an adapted version of the IE prevention guidelines for Kazakhstan.
Conclusions. Thus, the implementation of IE prevention measures in Kazakhstan is a concern, specifically the low level of awareness among dentists about the guiding principles of prevention. In addition, there was a noted need for the development of a locally adapted IE prevention guideline for Kazakhstan.
Keywords. Infective endocarditis, dentists, antibiotic prophylaxis.
Zhumakyz Kussainova 1, https://orcide.org/0000-0002-5356-0461
Tolkyn Bulegenov 1, https://orcide.org/0000-0001-6145-9649
Sholpan Abralina1, https://orcide.org/0009-0005-1555-1993
Zhazira Zhapar 2, https://orcide.org/0000-0001-6672-1116
Umitzhan Samarova 1, https://orcide.org/0000-0003-3320-7115
Zaituna Khismetova 1, https://orcid.org/0000-0001-5937-3045
Zhanara Ibrayeva1, https://orcide.org/ 0000-0001-7298-7869
Askar Abiltayev 3, https://orcide.org/000-0003-4127-2347
Olga Tashtemirova 3, https://orcide.org/000-0002-7537-2808
Guzyal Abilmazhinova 3, https://orcide.org/0000-0003-0007-9890
Gulzhanat Jakova 4, https://orcide.org/0000-0002-9479-5419
Острый и подострый эндокардит (инфекционный эндокардит). Версия: Клинические протоколы МЗ РК – 2019 (Казахстан). https://diseases.medelement.com/disease/ostryi-i-podostryi-endokardit-infektsionnyi-endokardit-2019/16483 (Дата обращения: 27.06.2024).
2. Alkhouli M., Alqahtani F., Alhajji M., Berzingi C.O., Sohail M.R. Clinical and Economic Burden of Hospitalizations for Infective Endocarditis in the United States. Mayo Clin Proc. 2020. 95: 858–66.
3. Cahill T.J., Harrison J.L., Jewell P. et al. Antibiotic prophylaxis for infective endocarditis: a systematic review and meta-analysis. Heart. 2017. 103: 937–44.
4. Chen H., Zhan Y., Zhang K. et al. The Global, Regional, and National Burden and Trends of Infective Endocarditis From 1990 to 2019: Results From the Global Burden of Disease Study 2019. Front Med. 2022. 9: 774224
5. Delgado V., Ajmone Marsan N., De Waha S. et al. 2023 ESC Guidelines for the management of endocarditis. European Heart Journal. 2023. 44: 3948–4042.
6. Duval X., Delahaye F., Alla F. et al. Temporal Trends in Infective Endocarditis in the Context of Prophylaxis Guideline Modifications. Journal of the American College of Cardiology. 2012. 59: 1968–76.
7. Hammond-Haley M., Hartley A., Al-Khayatt B.M., et al. Trends in the incidence and mortality of infective endocarditis in high-income countries between 1990 and 2019. Int J Cardiol 2023. 371: 441–51.
8. Nakatani S., Ohara T., Ashihara K., et al. Jcs 2017 Guideline On Prevention And Treatment Of Infective Endocarditis. Circ J. 2019. 83: 1767–809.
Number of Views: 116
Bibliography link
Kussainova Zh., Bulegenov T., Abralina Sh., Zhapar Zh., Samarova U., Khismetova Z., Ibrayeva Zh., Abiltayev A., Tashtemirova O., Abilmazhinova G., Jakova G. The application of guidelines for the prevention of infective endocarditis by dentists in Kazakhstan: a cross-sectional study // Nauka i Zdravookhranenie [Science & Healthcare]. 2024. Vol.26 (4), pp. 117-124. doi 10.34689/SH.2024.26.4.015Related publications:
VIRAL HEPATITIS IN KAZAKHSTAN: REGIONAL EPIDEMIOLOGICAL OVERVIEW
PREDICTORS OF ANTIVIRAL THERAPY INEFFECTIVENESS IN CHRONIC HEPATITIS C: A MATCHED CASE-CONTROL STUDY IN ALMATY, A MAJOR METROPOLIS OF KAZAKHSTAN
МЕДИКО – СОЦИАЛЬНЫЕ ОСОБЕННОСТИ ПРИВЕРЖЕННОСТИ К ЛЕЧЕНИЮ БОЛЬНЫХ С ХРОНИЧЕСКИМ ПАНКРЕАТИТОМ
PATHOGENETIC ASSESSMENT OF CLINICAL AND INSTRUMENTAL PARAMETERS OF THE LUNGS IN PATIENTS WITH DIABETES MELLITUS
THE FREQUENCY AND EFFICACY ASSESSMENT OF RADIOIODINE THERAPY FOR DISTANT METASTASES OF THYROID CANCER